JOHNSON & JOHNSON

Official Publications Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 16:00:02 2024-05-10 EDT			After market 17:02:20
149.9 ^USD	+0.04%		150	+0.04%

05-09	J&J: technological update in cardiac arrhythmia	CF
05-07	Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs	RE

Official Publications

1st-half-year results	22-07-18	CO
SEC Filing 8K	22-07-18	CO
Dividends	22-07-17	CO
SEC Filing 10Q-1	22-04-28	CO
SEC Filing 8K	22-04-27	CO
Slide show Q1	22-04-18	CO
SEC Filing 8K	22-04-18	CO
1st quarter results	22-04-18	CO
SEC Filing 8K	22-01-05	CO

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW